These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 30191367)

  • 1. Derivatization of common antidepressant drugs increases inhibition of acid sphingomyelinase and reduces induction of phospholipidosis.
    Rhein C; Löber S; Gmeiner P; Gulbins E; Tripal P; Kornhuber J
    J Neural Transm (Vienna); 2018 Dec; 125(12):1837-1845. PubMed ID: 30191367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional Inhibitors of Acid Sphingomyelinase (FIASMAs): a novel pharmacological group of drugs with broad clinical applications.
    Kornhuber J; Tripal P; Reichel M; Mühle C; Rhein C; Muehlbacher M; Groemer TW; Gulbins E
    Cell Physiol Biochem; 2010; 26(1):9-20. PubMed ID: 20502000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alternative splicing of SMPD1 coding for acid sphingomyelinase in major depression.
    Rhein C; Reichel M; Kramer M; Rotter A; Lenz B; Mühle C; Gulbins E; Kornhuber J
    J Affect Disord; 2017 Feb; 209():10-15. PubMed ID: 27866044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acid sphingomyelinase (ASM) and COVID-19: A review of the potential use of ASM inhibitors against SARS-CoV-2.
    Pauletto PJT; Delgado CP; da Rocha JBT
    Cell Biochem Funct; 2023 Apr; 41(3):284-295. PubMed ID: 36929117
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Pauletto P; Bortoli M; Bright FO; Delgado CP; Nogara PA; Orian L; da Rocha JBT
    J Biomol Struct Dyn; 2023 Nov; 41(19):9562-9575. PubMed ID: 36447407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tricyclic antidepressants induce sphingomyelinase deficiency in fibroblast and neuroblastoma cell cultures.
    Albouz S; Hauw JJ; Berwald-Netter Y; Boutry JM; Bourdon R; Baumann N
    Biomedicine; 1981 Dec; 35(7-8):218-20. PubMed ID: 6285997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of lysosomal acid sphingomyelinase by agents which reverse multidrug resistance.
    Jaffrézou JP; Chen KG; Durán GE; Muller C; Bordier C; Laurent G; Sikic BI; Levade T
    Biochim Biophys Acta; 1995 Apr; 1266(1):1-8. PubMed ID: 7718613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The tricyclic antidepressant desipramine causes proteolytic degradation of lysosomal sphingomyelinase in human fibroblasts.
    Hurwitz R; Ferlinz K; Sandhoff K
    Biol Chem Hoppe Seyler; 1994 Jul; 375(7):447-50. PubMed ID: 7945993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of acid sphingomyelinase disrupts LYNUS signaling and triggers autophagy.
    Justice MJ; Bronova I; Schweitzer KS; Poirier C; Blum JS; Berdyshev EV; Petrache I
    J Lipid Res; 2018 Apr; 59(4):596-606. PubMed ID: 29378782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acid Sphingomyelinase, a Lysosomal and Secretory Phospholipase C, Is Key for Cellular Phospholipid Catabolism.
    Breiden B; Sandhoff K
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of tricyclic antidepressants on sphingomyelinase and other sphingolipid hydrolases in C6 cultured glioma cells.
    Albouz S; Vanier MT; Hauw JJ; Le Saux F; Boutry JM; Baumann N
    Neurosci Lett; 1983 Apr; 36(3):311-5. PubMed ID: 6306526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of novel functional inhibitors of acid sphingomyelinase.
    Kornhuber J; Muehlbacher M; Trapp S; Pechmann S; Friedl A; Reichel M; Mühle C; Terfloth L; Groemer TW; Spitzer GM; Liedl KR; Gulbins E; Tripal P
    PLoS One; 2011; 6(8):e23852. PubMed ID: 21909365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acid sphingomyelinase deactivation post-ischemia promotes brain angiogenesis and remodeling by small extracellular vesicles.
    Mohamud Yusuf A; Hagemann N; Zhang X; Zafar M; Hussner T; Bromkamp C; Martiny C; Tertel T; Börger V; Schumacher F; Solari FA; Hasenberg M; Kleinschnitz C; Doeppner TR; Kleuser B; Sickmann A; Gunzer M; Giebel B; Kolesnick R; Gulbins E; Hermann DM
    Basic Res Cardiol; 2022 Dec; 117(1):43. PubMed ID: 36038749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the small molecule ARC39, a direct and specific inhibitor of acid sphingomyelinase in vitro.
    Naser E; Kadow S; Schumacher F; Mohamed ZH; Kappe C; Hessler G; Pollmeier B; Kleuser B; Arenz C; Becker KA; Gulbins E; Carpinteiro A
    J Lipid Res; 2020 Jun; 61(6):896-910. PubMed ID: 32156719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of ceramide in major depressive disorder.
    Kornhuber J; Reichel M; Tripal P; Groemer TW; Henkel AW; Mühle C; Gulbins E
    Eur Arch Psychiatry Clin Neurosci; 2009 Nov; 259 Suppl 2():S199-204. PubMed ID: 19876679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. mRNA Expression of
    Rhein C; Zoicas I; Marx LM; Zeitler S; Hepp T; von Zimmermann C; Mühle C; Richter-Schmidinger T; Lenz B; Erim Y; Reichel M; Gulbins E; Kornhuber J
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional inhibition or genetic deletion of acid sphingomyelinase bacteriostatically inhibits Anaplasma phagocytophilum infection in vivo.
    Naimi WA; Gumpf JJ; Cockburn CL; Camus S; Chalfant CE; Li PL; Carlyon JA
    Pathog Dis; 2021 Jan; 79(1):. PubMed ID: 33220685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulating cancer cell survival by targeting intracellular cholesterol transport.
    Kuzu OF; Gowda R; Noory MA; Robertson GP
    Br J Cancer; 2017 Aug; 117(4):513-524. PubMed ID: 28697173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of drugs inducing phospholipidosis by novel in vitro data.
    Muehlbacher M; Tripal P; Roas F; Kornhuber J
    ChemMedChem; 2012 Nov; 7(11):1925-34. PubMed ID: 22945602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition by vitamin E of drug accumulation and of phospholipidosis induced by desipramine and other cationic amphiphilic drugs in human cultured cells.
    Scuntaro I; Kientsch U; Wiesmann UN; Honegger UE
    Br J Pharmacol; 1996 Nov; 119(5):829-34. PubMed ID: 8922728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.